Update on Novavax

One of the recent additions to the global COVID-19 vaccine roster comes from Novavax, a vaccine poised to hit worldwide markets & hopefully make a difference in the problem of global vaccine equity.

Novavax’s shot uses a tried-and-true technology: it’s called a protein subunit or acellular vaccine. It’s the same tech used to make the vaccines already available to protect us from pertussis, pneumonia, and hepatitis B. Protein subunit vaccines have several advantages, including that they are well-tolerated, relatively cheap, relatively low-tech to ma…